Mereo BioPharma Group plc (MREO) Financials
MREO Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-06-30 | 101.8 million | 28.9 million |
| 2023-03-31 | ? | ? |
| 2022-12-31 | 106.6 million | 31.7 million |
| 2022-09-30 | 120.1 million | 42.8 million |
MREO Free Cash Flow and Stock based compensation
No data available :(
MREO Net Income
No data available :(
MREO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-06-30 | 53.2 million | - | 1.8 million |
| 2023-03-31 | - | - | - |
| 2022-12-31 | 68.2 million | - | 2.0 million |
| 2022-09-30 | 85.0 million | - | - |
MREO Shares Outstanding
MREO Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-06-30 | 524650 | 12.3 million | - | - |
| 2023-03-31 | - | - | - | - |
| 2022-12-31 | 1475 | 16.5 million | - | - |
| 2022-09-30 | - | - | - | - |
MREO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-06-30 | 11.1 million | 4.5 million |
| 2023-03-31 | - | - |
| 2022-12-31 | - | -390791 |
| 2022-09-30 | - | - |
MREO
Price: $3.02
52 week price:
Earnings Per Share: -0.32 USD
P/E Ratio: -12.16
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 278100
Market Capitalization: 439.0 million